F18.98 Inhalant use, unspecified with other inhalant-induced disorders

Name of the Condition

• Common Name: Inhalant Use Disorder with Other Inhalant-Induced Disorders
• Medical Term: Inhalant Use, Unspecified with Other Inhalant-Induced Disorders

Summary

Inhalant use, unspecified with other inhalant-induced disorders, refers to the misuse of inhalants—substances that produce chemical vapors—for their psychoactive effects, accompanied by additional inhalant-related health issues. This condition involves the intentional inhalation of substances like glue, paint thinners, or aerosols, which can lead to acute intoxication, dependence, or other substance-related complications. Inhalant use may result in significant physical and psychological harm, affecting an individual's health and daily functioning.

Causes

Inhalant use is primarily driven by the repeated misuse of inhalants for their psychoactive effects. Inhalants are often everyday household or industrial products, such as glue, paint thinners, aerosols, or solvents. The misuse of these substances can lead to dependence and related health issues.

Risk Factors

• Adolescents and young adults are more likely to experiment with inhalants.
• Individuals with a history of substance abuse or mental health disorders.
• Accessibility to inhalant products.
• Lack of proper supervision or guidance.

Symptoms

• Intense cravings or compulsive inhalant use.
• Coordination problems, dizziness, or lethargy.
• Unexplained behavioral changes such as aggression or mood swings.
• Cognitive impairment.
• Additional inhalant-induced disorders (e.g., neurological, respiratory, or cardiac issues).

Diagnosis

Diagnosis involves a thorough clinical evaluation, including a detailed history of inhalant use and associated symptoms. Healthcare providers assess for signs of inhalant misuse and any co-occurring disorders. Laboratory tests or imaging may be used to identify specific inhalant-induced complications, while ruling out other medical conditions.

Treatment Options

Treatment typically includes behavioral therapies, such as cognitive-behavioral therapy, to address inhalant use and related disorders. Medications may be prescribed to manage withdrawal symptoms or co-occurring conditions. Supportive care, such as counseling or rehabilitation programs, is often recommended to promote recovery and prevent relapse.

Prognosis and Follow-Up

Prognosis depends on the severity of inhalant use and the presence of other disorders. Early intervention and consistent follow-up care improve outcomes. Regular monitoring for relapse and ongoing support are essential to address long-term health risks and maintain recovery.

Complications

• Neurological damage (e.g., cognitive decline, memory loss).
• Respiratory or cardiac issues.
• Organ damage (e.g., liver, kidney).
• Increased risk of accidents or injuries due to impaired coordination.

Lifestyle & Prevention

• Avoid exposure to inhalant products, especially in unsupervised settings.
• Educate individuals about the risks of inhalant misuse.
• Promote healthy coping mechanisms and stress management.
• Encourage open communication about substance use concerns.

When to Seek Professional Help

Seek medical attention if experiencing severe symptoms (e.g., difficulty breathing, chest pain) or if inhalant use is interfering with daily life. Consult a healthcare provider for persistent cravings, withdrawal symptoms, or signs of co-occurring disorders.

Tips for Medical Coders

Document the presence of inhalant use and any associated disorders clearly. Ensure the code F18.98 is used when inhalant use is unspecified and accompanied by other inhalant-induced conditions. Verify that clinical details support the diagnosis and align with coding guidelines.